Our results reveal that the growth of patient-derived HB cultures is strongly associated with tumor burden and recurrence in patients with VHL, suggesting that the in vitro proliferation profile may mirror disease features related to CNS-HB progression. This evidence concerns the gene VHL and hemoglobin measurement.